The 10x Radar
Subscribe
Sign in
Home
Chat
10x Deep Dives
10x Portfolio
10x Watchlist
Management Talks
Compounding Knowledge
About
Latest
Top
Discussions
PolyPid : The Biotech That Broke My Rules
A derisked Phase 3 win, stealth platform, and billion-dollar TAM
Jul 1
•
Aditya
9
Share this post
The 10x Radar
PolyPid : The Biotech That Broke My Rules
Copy link
Facebook
Email
Notes
More
1
June 2025
David Beckham, DNA Tests, and a Business You Get for Free
A stock, a supplement brand, and a biotech twist
Jun 12
•
Aditya
5
Share this post
The 10x Radar
David Beckham, DNA Tests, and a Business You Get for Free
Copy link
Facebook
Email
Notes
More
5
May 2025
10x Radar Portfolio: Q1 2025
Lessons, Losses, and the Weird Joy of Getting It Less Wrong
May 24
•
Aditya
9
Share this post
The 10x Radar
10x Radar Portfolio: Q1 2025
Copy link
Facebook
Email
Notes
More
5
Management Talks: Inside Optex Systems
A 1:1 with Optex Systems’ CEO on armored vehicle optics, prime contractor signals, and staying mission-critical across budgets
May 21
•
Aditya
10
Share this post
The 10x Radar
Management Talks: Inside Optex Systems
Copy link
Facebook
Email
Notes
More
Management Talks: Inside the Engine Room at NTG Clarity Networks
A 1:1 with NTG Clarity’s VP Strategy on Saudi growth, sticky contracts and what keeps them up at night.
May 16
•
Aditya
9
Share this post
The 10x Radar
Management Talks: Inside the Engine Room at NTG Clarity Networks
Copy link
Facebook
Email
Notes
More
2
NTG Clarity: The One I Almost Missed
Founder-led IT services firm quietly compounding and a delivery model that beats the big guys on fit, not just cost
May 10
•
Aditya
14
Share this post
The 10x Radar
NTG Clarity: The One I Almost Missed
Copy link
Facebook
Email
Notes
More
5
April 2025
Optex Systems: When the Primes Win, This One Follows
A $40M defense subcontractor compounding quietly under the radar — backed by backlog, ROIC, and multi-year contracts
Apr 21
•
Aditya
10
Share this post
The 10x Radar
Optex Systems: When the Primes Win, This One Follows
Copy link
Facebook
Email
Notes
More
4
The ROIC × Reinvestment Framework (Part 2)
Decoding Expectations with ROIC × Reinvestment and And Why I’m Buying More When the Market Misprices Growth
Apr 6
•
Aditya
12
Share this post
The 10x Radar
The ROIC × Reinvestment Framework (Part 2)
Copy link
Facebook
Email
Notes
More
1
The ROIC × Reinvestment Framework (Part 1)
A Practical Guide to Capital Efficiency — and the Lens I’m Learning to Use
Apr 6
•
Aditya
11
Share this post
The 10x Radar
The ROIC × Reinvestment Framework (Part 1)
Copy link
Facebook
Email
Notes
More
2
A Hard Revisit: What Really Happened at Evome (TSXV: EVMT)
A post-mortem on a small-cap turnaround that unraveled — and raised more questions than answers.
Apr 3
•
Aditya
9
Share this post
The 10x Radar
A Hard Revisit: What Really Happened at Evome (TSXV: EVMT)
Copy link
Facebook
Email
Notes
More
4
March 2025
Management Talks: In-Depth with Evome Medical Technologies
Key insights from my conversation with Evome’s leadership on strategy, execution, and what’s next.
Mar 8
•
Aditya
11
Share this post
The 10x Radar
Management Talks: In-Depth with Evome Medical Technologies
Copy link
Facebook
Email
Notes
More
16
February 2025
SECURE Waste Infrastructure: The Market’s Blind Spot, and the Opportunity Behind It
Rebranded Leader with Strong Growth Potential, Smart Capital Allocation, and Market Mispricing
Feb 17
•
Aditya
26
Share this post
The 10x Radar
SECURE Waste Infrastructure: The Market’s Blind Spot, and the Opportunity Behind It
Copy link
Facebook
Email
Notes
More
9
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
